SMCP S.A. (EPA:SMCP)
5.66
+0.49 (9.48%)
Aug 5, 2025, 5:35 PM CET
Sage Therapeutics Cash Flow Statement
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2016 - 2020 |
---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2016 - 2020 |
Net Income | 15.1 | -23.6 | 11.2 | 51.3 | 23.9 | -102.2 | Upgrade |
Depreciation & Amortization | 153.2 | 163.5 | 155.9 | 155.4 | 147.2 | 170.3 | Upgrade |
Asset Writedown & Restructuring Costs | 34.8 | 34.8 | 25 | 9.8 | 29.8 | 82.6 | Upgrade |
Stock-Based Compensation | - | - | - | 5.6 | 6.7 | 9.2 | Upgrade |
Other Operating Activities | 16.8 | 29.9 | 23 | 32.3 | 33 | 17.5 | Upgrade |
Change in Accounts Receivable | 10.3 | 16.3 | -2.6 | -5.5 | -7.1 | 5.9 | Upgrade |
Change in Inventory | 27.9 | 25.2 | 9.7 | -58 | -3.4 | 21.1 | Upgrade |
Change in Accounts Payable | 1.1 | -12.2 | -10.8 | 18.1 | 16 | -1 | Upgrade |
Operating Cash Flow | 259.2 | 233.9 | 211.4 | 209 | 246.1 | 203.4 | Upgrade |
Operating Cash Flow Growth | 22.32% | 10.64% | 1.15% | -15.07% | 20.99% | 0.99% | Upgrade |
Capital Expenditures | -36.4 | -43.7 | -54.2 | -45.5 | -42.7 | -57.8 | Upgrade |
Sale of Property, Plant & Equipment | 2.3 | 2.5 | 3.5 | - | 0.6 | - | Upgrade |
Cash Acquisitions | - | - | -6.1 | - | -0.1 | -2.9 | Upgrade |
Investment in Securities | 2.6 | 2.2 | -0.6 | 0.9 | -1.1 | 1.7 | Upgrade |
Other Investing Activities | 0.1 | 0.2 | 0.1 | - | - | - | Upgrade |
Investing Cash Flow | -31.4 | -38.8 | -57.3 | -44.6 | -43.3 | -59 | Upgrade |
Long-Term Debt Issued | - | - | 32.6 | - | 55.4 | 144.9 | Upgrade |
Total Debt Issued | 18.8 | - | 32.6 | - | 55.4 | 144.9 | Upgrade |
Short-Term Debt Repaid | - | -55.5 | -76.2 | -85 | -114.9 | - | Upgrade |
Long-Term Debt Repaid | - | -127.5 | -128.2 | -120.9 | -120.4 | -200.4 | Upgrade |
Total Debt Repaid | -196.2 | -183 | -204.4 | -205.9 | -235.3 | -200.4 | Upgrade |
Net Debt Issued (Repaid) | -177.4 | -183 | -171.8 | -205.9 | -179.9 | -55.5 | Upgrade |
Repurchase of Common Stock | -1.7 | -0.4 | -2.4 | -7.4 | -5.5 | - | Upgrade |
Other Financing Activities | -14.4 | -19.2 | -17.1 | -9.4 | -14.2 | -12.7 | Upgrade |
Financing Cash Flow | -193.5 | -202.6 | -191.3 | -222.7 | -199.6 | -68.2 | Upgrade |
Foreign Exchange Rate Adjustments | -1.5 | 0.5 | -0.5 | 0.2 | 1.5 | -1 | Upgrade |
Miscellaneous Cash Flow Adjustments | -0.4 | - | - | - | - | - | Upgrade |
Net Cash Flow | 32.4 | -7 | -37.7 | -58.1 | 4.7 | 75.2 | Upgrade |
Free Cash Flow | 222.8 | 190.2 | 157.2 | 163.5 | 203.4 | 145.6 | Upgrade |
Free Cash Flow Growth | 43.10% | 20.99% | -3.85% | -19.62% | 39.70% | 12.52% | Upgrade |
Free Cash Flow Margin | 18.15% | 15.70% | 12.78% | 13.56% | 19.58% | 16.68% | Upgrade |
Free Cash Flow Per Share | 2.90 | 2.53 | 2.00 | 2.06 | 2.56 | 1.97 | Upgrade |
Cash Interest Paid | 18.9 | 18.9 | 16.3 | 9.9 | 14.6 | 12.9 | Upgrade |
Cash Income Tax Paid | 4.1 | 10.1 | 16.9 | 12.2 | 5 | 2.2 | Upgrade |
Levered Free Cash Flow | 174.01 | 134.61 | 99.81 | 131.98 | 173.93 | 111.7 | Upgrade |
Unlevered Free Cash Flow | 192.01 | 153.74 | 116.75 | 146.1 | 190.11 | 128.83 | Upgrade |
Change in Net Working Capital | -48.2 | -22.2 | 20.2 | 35.4 | -21.6 | -8.5 | Upgrade |
Updated Feb 27, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.